Skip to main content

Table 3 Reasons for Discontinuation

From: The Women’s Health Initiative cancer survivorship clinic incorporating electronic patient-reported outcomes: a study protocol for the Linking You to Support and Advice (LYSA) randomized controlled trial

At the participant’s own request

Death

Intercurrent illness or condition that would, in the judgment of the Principal Investigator, significantly affect assessment of clinical status

Evidence of disease recurrence during the study

The study is terminated for any reason

The participant withdraws consent for follow-up

Non-completion of two consecutive ePRO surveys

  1. ePRO Electronic patient reported outcome
Back to article page

Pilot and Feasibility Studies

ISSN: 2055-5784